Objective: To determine whether treatment with recombinant human thrombomodulin (rhTM) increases survival among severe septic patients with sepsis-induced disseminated intravascular coagulation (DIC
Additional file 1: Table S1. Blood examination results. Blood examination at postoperation day (POD)-2 indicated DIC with a fibrinolytic phenotype, which ameliorated after the operation
